2006
DOI: 10.1001/jama.296.1.87
|View full text |Cite
|
Sign up to set email alerts
|

Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily

Abstract: Initiation of recurrent daily intake of 4 g of acetaminophen in healthy adults is associated with ALT elevations and concomitant treatment with opioids does not seem to increase this effect. History of acetaminophen ingestion should be considered in the differential diagnosis of serum aminotransferase elevations, even in the absence of measurable serum acetaminophen concentrations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

22
364
4
10

Year Published

2006
2006
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 587 publications
(400 citation statements)
references
References 22 publications
22
364
4
10
Order By: Relevance
“…Moreover, there is evidence that the maximum recommended dose (i.e., 4 g/day) can induce mild to moderate hepatic cytolysis, even in healthy individuals (Watkins et al. 2006; Winnike et al. 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, there is evidence that the maximum recommended dose (i.e., 4 g/day) can induce mild to moderate hepatic cytolysis, even in healthy individuals (Watkins et al. 2006; Winnike et al. 2010).…”
Section: Introductionmentioning
confidence: 99%
“…In recent time, the safety of acetaminophen even at therapeutic doses has generated considerable debate (Jalan et al, 2006). Results of recent study by Watkins and co-workers as well as of other studies have reopened the controversies on the therapeutic safety of acetaminophen on long term continuous treatment (Kwan et al, 1995;Yin et al, 2001;Watkins et al, 2006). Acute liver injury has been reported in patients on therapeutic doses of acetaminophen (Critchley et al, 1986;Yin et al, 2001;Watkins et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Results of recent study by Watkins and co-workers as well as of other studies have reopened the controversies on the therapeutic safety of acetaminophen on long term continuous treatment (Kwan et al, 1995;Yin et al, 2001;Watkins et al, 2006). Acute liver injury has been reported in patients on therapeutic doses of acetaminophen (Critchley et al, 1986;Yin et al, 2001;Watkins et al, 2006). Acetaminophen-induced hepatic injury is reported to be mediated through an increased lipid peroxidation in hepatic tissues (Schnellman, 2001;Bessems and Vermeulen, 2001).…”
Section: Introductionmentioning
confidence: 99%
“…After the addition was completed, the reaction mixture was stirred at room temperature for 2 h. The resulting solid was filtered and recrystallized from ethanol/water (10:1) to furnish the corresponding 5 as a white crystalline solid. (8). Two grams of 5a (6 mmol) was suspended in 10 mL of 10% aqueous NaOH, and after 30 min, suspension turned into a solution.…”
Section: Methods Bmentioning
confidence: 99%
“…1) that interferes with targets involved in pain and thermoregulation, including COX-mediated prostaglandin synthesis, and vanilloid and cannabinoid receptor systems. 7 Although APAP shows low incidence of gastrointestinal and other COX-related adverse effects as compared with most NSAIDs, it is well established that APAP can cause hepatotoxicity 8 and nephrotoxicity. These effects can potentially be lethal, 9,10 particularly after ingestion of large doses or after chronic use of small doses when liver function is already compromised (e.g., in the elderly and in patients with alcoholic liver disease).…”
Section: Introductionmentioning
confidence: 99%